131 related articles for article (PubMed ID: 18667841)
21. Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis.
Iwata C; Kano MR; Komuro A; Oka M; Kiyono K; Johansson E; Morishita Y; Yashiro M; Hirakawa K; Kaminishi M; Miyazono K
Cancer Res; 2007 Nov; 67(21):10181-9. PubMed ID: 17974958
[TBL] [Abstract][Full Text] [Related]
22. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
[TBL] [Abstract][Full Text] [Related]
23. COX-2 expression is correlated with VEGF-C, lymphangiogenesis and lymph node metastasis in human cervical cancer.
Liu H; Xiao J; Yang Y; Liu Y; Ma R; Li Y; Deng F; Zhang Y
Microvasc Res; 2011 Sep; 82(2):131-40. PubMed ID: 21600223
[TBL] [Abstract][Full Text] [Related]
24. [Effects of endostatin on the growth and lymphangiogenesis of Lewis lung carcinoma xenograft in mice].
Dong XP; Xiao TH; Meng LB; Yun CH; Tian H
Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(43):3091-3. PubMed ID: 21211334
[TBL] [Abstract][Full Text] [Related]
25. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.
Feng Y; Wang W; Hu J; Ma J; Zhang Y; Zhang J
Anat Rec (Hoboken); 2010 May; 293(5):802-12. PubMed ID: 20225197
[TBL] [Abstract][Full Text] [Related]
26. A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities.
Xu Y; Lu W; Yang P; Peng W; Wang C; Li M; Li Y; Li G; Meng N; Lin H; Kan L; Wang S; Yang S; Yu L; Zhao Y
BMC Cancer; 2015 Jul; 15():525. PubMed ID: 26187637
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-6 signalling regulates vascular endothelial growth factor-C synthesis and lymphangiogenesis in human oral squamous cell carcinoma.
Shinriki S; Jono H; Ueda M; Ota K; Ota T; Sueyoshi T; Oike Y; Ibusuki M; Hiraki A; Nakayama H; Shinohara M; Ando Y
J Pathol; 2011 Sep; 225(1):142-50. PubMed ID: 21710490
[TBL] [Abstract][Full Text] [Related]
28. Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein.
Zhang D; Li B; Shi J; Zhao L; Zhang X; Wang C; Hou S; Qian W; Kou G; Wang H; Guo Y
Cancer Res; 2010 Mar; 70(6):2495-503. PubMed ID: 20197464
[TBL] [Abstract][Full Text] [Related]
29. Adiponectin promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-27b through a CaMKII/AMPK/p38 signaling pathway in human chondrosarcoma cells.
Huang CY; Chang AC; Chen HT; Wang SW; Lo YS; Tang CH
Clin Sci (Lond); 2016 Sep; 130(17):1523-33. PubMed ID: 27252405
[TBL] [Abstract][Full Text] [Related]
30. Kallistatin inhibits lymphangiogenesis and lymphatic metastasis of gastric cancer by downregulating VEGF-C expression and secretion.
Ma C; Luo C; Yin H; Zhang Y; Xiong W; Zhang T; Gao T; Wang X; Che D; Fang Z; Li L; Xie J; Huang M; Zhu L; Jiang P; Qi W; Zhou T; Yang Z; Wang W; Ma J; Gao G; Yang X
Gastric Cancer; 2018 Jul; 21(4):617-631. PubMed ID: 29243194
[TBL] [Abstract][Full Text] [Related]
31. Role of interleukin-17 in lymphangiogenesis in non-small-cell lung cancer: Enhanced production of vascular endothelial growth factor C in non-small-cell lung carcinoma cells.
Chen X; Xie Q; Cheng X; Diao X; Cheng Y; Liu J; Xie W; Chen Z; Zhu B
Cancer Sci; 2010 Nov; 101(11):2384-90. PubMed ID: 20825419
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival.
Chen Z; Varney ML; Backora MW; Cowan K; Solheim JC; Talmadge JE; Singh RK
Cancer Res; 2005 Oct; 65(19):9004-11. PubMed ID: 16204074
[TBL] [Abstract][Full Text] [Related]
33. Metastasis-associated in colon cancer-1 upregulates vascular endothelial growth factor-C/D to promote lymphangiogenesis in human gastric cancer.
Sun L; Duan J; Jiang Y; Wang L; Huang N; Lin L; Liao Y; Liao W
Cancer Lett; 2015 Feb; 357(1):242-253. PubMed ID: 25444928
[TBL] [Abstract][Full Text] [Related]
34. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
35. Qingjie Fuzheng Granule suppresses lymphangiogenesis in colorectal cancer via the VEGF-C/VEGFR-3 dependent PI3K/AKT pathway.
Huang B; Lu Y; Gui M; Guan J; Lin M; Zhao J; Mao Q; Lin J
Biomed Pharmacother; 2021 May; 137():111331. PubMed ID: 33578235
[TBL] [Abstract][Full Text] [Related]
36. Tumor-derived interleukin-1 promotes lymphangiogenesis and lymph node metastasis through M2-type macrophages.
Watari K; Shibata T; Kawahara A; Sata K; Nabeshima H; Shinoda A; Abe H; Azuma K; Murakami Y; Izumi H; Takahashi T; Kage M; Kuwano M; Ono M
PLoS One; 2014; 9(6):e99568. PubMed ID: 24924428
[TBL] [Abstract][Full Text] [Related]
37. A heparin conjugate, LHbisD4, inhibits lymphangiogenesis and attenuates lymph node metastasis by blocking VEGF-C signaling pathway.
Choi JU; Chung SW; Al-Hilal TA; Alam F; Park J; Mahmud F; Jeong JH; Kim SY; Byun Y
Biomaterials; 2017 Sep; 139():56-66. PubMed ID: 28586719
[TBL] [Abstract][Full Text] [Related]
38. KAI1 inhibits lymphangiogenesis and lymphatic metastasis of pancreatic cancer in vivo.
Liu X; Guo XZ; Li HY; Chen J; Ren LN; Wu CY
Hepatobiliary Pancreat Dis Int; 2014 Feb; 13(1):87-92. PubMed ID: 24463085
[TBL] [Abstract][Full Text] [Related]
39. The significance of lymphatic space invasion and its association with vascular endothelial growth factor-C expression in ovarian cancer.
Hisamatsu T; Mabuchi S; Sasano T; Kuroda H; Takahashi R; Matsumoto Y; Kawano M; Kozasa K; Takahashi K; Sawada K; Matsuo K; Tamada Y; Morii E; Kitadai Y; Kimura T
Clin Exp Metastasis; 2015 Dec; 32(8):789-98. PubMed ID: 26443563
[TBL] [Abstract][Full Text] [Related]
40. Tumor necrosis factor superfamily 15 promotes lymphatic metastasis via upregulation of vascular endothelial growth factor-C in a mouse model of lung cancer.
Qin T; Huang D; Liu Z; Zhang X; Jia Y; Xian CJ; Li K
Cancer Sci; 2018 Aug; 109(8):2469-2478. PubMed ID: 29890027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
